Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Psoriasis: HELP
K. Papp
Based on 16 articles published since 2009
(Why 16 articles?)
||||
Expertise Level
The expertise of K. Papp ranks in the
  • Top 0.55%
  • ... of 37,586 published authors worldwide on Psoriasis
  • ... from 2009 through 2019
  • ... based on contributions to 16 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Work Locations
Details
Most likely:    Miscellaneous institutions in Waterloo      
2018
  • McMaster University, Faculty of Health Sciences, Hamilton, ON, Canada; University of Toronto, Faculty of Medicine, Toronto, ON, Canada. · Skin Centre for Dermatology, Peterborough, ON, Canada; Probity Medical Research, Waterloo, ON Canada; Queen's University, Kingston, ON Canada. · Probity Medical Research, Waterloo, ON Canada; K Papp Clinical Research, Waterloo, ON Canada. · Pubmed 29562088
2017
  • Clinical Research, Waterloo, ON, Canada. · Probity Medical Research, Waterloo, ON, Canada. · Sorbonne Paris Cité Université Paris Diderot, Department of Dermatology, AP-HP HP Hôpital Saint-Louis, INSERM U1163, Institut Imagine, Paris, France. · Dermatology Unit, Department of Biomedical Sciences, Humanitas University, Rozzano - Milan, Italy. · Department of Medicine (Dermatology), The University of Melbourne, St Vincent's Hospital Melbourne, Australia. · Skin & Cancer Foundation Inc., Carlton, Australia. · Probity Medical Research, Carlton, Australia. · SKiN Centre for Dermatology, ON, Canada. · Amgen Inc., Thousand Oaks, CA, U.S.A. · Psoriasis Research and Treatment Center, University Hospital Charité, Berlin, Germany. · Veracity Clinical Research, Woolloongabba, Queensland, Australia. · Probity Medical Research, Woolloongabba, Queensland, Australia. · University of Connecticut Health Center, Farmington, CT, U.S.A. · Probity Medical Research, Farmington, CT, U.S.A. · Pubmed 28755394
  • Ann Arbor Pharmacometrics Group (A2PG), Inc., Ann Arbor, Michigan, USA. · Probity Medical Research and K Papp Clinical Research Inc., Waterloo, Ontario, Canada. · Pfizer Inc., Groton, Connecticut, USA. · Pubmed 28317328
2015
  • Skin Centre for Dermatology, Peterborough, ON, Canada; Probity Medical Research, Waterloo, ON, Canada. · K. Papp Clinical Research, Waterloo, ON, Canada; Probity Medical Research, Waterloo, ON, Canada. · Pubmed 26382906
  • Probity Medical Research, 135 Union Street East, Waterloo, ON, N2J 1C4, Canada. · Comprehensive Center for Inflammation Medicine, University Medical School Schleswig-Holstein, University of Lübeck, Lübeck, Germany. · SCIderm Research Institute and Dermatologikum Hamburg, Hamburg, Germany. · Division of General Dermatology, Department of Dermatology, Medical University of Vienna, Vienna, Austria. · Dalhousie University, Halifax, NS, Canada. · Laboratory for Investigative Dermatology, The Rockefeller University, New York, NY, U.S.A. · Department of Dermatology, Tufts Medical Center, Boston, MA, U.S.A. · Department of Dermatology, The Jikei University School of Medicine, Tokyo, Japan. · Merck & Co., Inc., Kenilworth, NJ, U.S.A. · Pubmed 26042589
  • Probity Medical Research, Waterloo, ON, Canada. · Eastern Virginia Medical School and Virginia Clinical Research, Inc., Norfolk, VA, U.S.A. · MEDTOX Scientific, Inc., St. Paul, MN, U.S.A. · Astellas Pharma Global Development, Northbrook, IL, U.S.A. · The Rockefeller University, New York, NY, U.S.A. · Pubmed 25704750
2014
  • Probity Medical Research, 135 Union Street East, Waterloo, ON, N2J 1C4, Canada. · Pubmed 23465037
2013
2012
2011
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 16 total) written by K. Papp about Psoriasis:

  • Brodalumab: A Review of Safety. 2018
  • Clinical similarity of the biosimilar ABP 501 compared with adalimumab after single transition: long-term results from a randomized controlled, double-blind, 52-week, phase III trial in patients with moderate-to-severe plaque psoriasis. 2017
  • Evaluating Dosage Optimality for Tofacitinib, an Oral Janus Kinase Inhibitor, in Plaque Psoriasis, and the Influence of Body Weight. 2017
  • Apremilast in the treatment of psoriasis and psoriatic arthritis. 2015
  • Tildrakizumab (MK-3222), an anti-interleukin-23p19 monoclonal antibody, improves psoriasis in a phase IIb randomized placebo-controlled trial. 2015
  • A phase 2a randomized, double-blind, placebo-controlled, sequential dose-escalation study to evaluate the efficacy and safety of ASP015K, a novel Janus kinase inhibitor, in patients with moderate-to-severe psoriasis. 2015
  • Disease characteristics in patients with and without psoriatic arthritis treated with etanercept. 2014
  • Effect of tofacitinib, a Janus kinase inhibitor, on haematological parameters during 12 weeks of psoriasis treatment. 2013
  • A randomized phase 2a efficacy and safety trial of the topical Janus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis. 2013
  • Safety results from a pooled analysis of randomized, controlled phase II and III clinical trials and interim data from an open-label extension trial of the interleukin-12/23 monoclonal antibody, briakinumab, in moderate to severe psoriasis. 2013
Show List of Full Article Records
Google Searches

Learn more about K. Papp using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Miscellaneous institutions in Waterloo
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Miscellaneous institutions in Waterloo
2018
  • McMaster University, Faculty of Health Sciences, Hamilton, ON, Canada; University of Toronto, Faculty of Medicine, Toronto, ON, Canada. · Skin Centre for Dermatology, Peterborough, ON, Canada; Probity Medical Research, Waterloo, ON Canada; Queen's University, Kingston, ON Canada. · Probity Medical Research, Waterloo, ON Canada; K Papp Clinical Research, Waterloo, ON Canada. · Pubmed 29562088
2017
  • Clinical Research, Waterloo, ON, Canada. · Probity Medical Research, Waterloo, ON, Canada. · Sorbonne Paris Cité Université Paris Diderot, Department of Dermatology, AP-HP HP Hôpital Saint-Louis, INSERM U1163, Institut Imagine, Paris, France. · Dermatology Unit, Department of Biomedical Sciences, Humanitas University, Rozzano - Milan, Italy. · Department of Medicine (Dermatology), The University of Melbourne, St Vincent's Hospital Melbourne, Australia. · Skin & Cancer Foundation Inc., Carlton, Australia. · Probity Medical Research, Carlton, Australia. · SKiN Centre for Dermatology, ON, Canada. · Amgen Inc., Thousand Oaks, CA, U.S.A. · Psoriasis Research and Treatment Center, University Hospital Charité, Berlin, Germany. · Veracity Clinical Research, Woolloongabba, Queensland, Australia. · Probity Medical Research, Woolloongabba, Queensland, Australia. · University of Connecticut Health Center, Farmington, CT, U.S.A. · Probity Medical Research, Farmington, CT, U.S.A. · Pubmed 28755394
  • Ann Arbor Pharmacometrics Group (A2PG), Inc., Ann Arbor, Michigan, USA. · Probity Medical Research and K Papp Clinical Research Inc., Waterloo, Ontario, Canada. · Pfizer Inc., Groton, Connecticut, USA. · Pubmed 28317328
2015
  • Skin Centre for Dermatology, Peterborough, ON, Canada; Probity Medical Research, Waterloo, ON, Canada. · K. Papp Clinical Research, Waterloo, ON, Canada; Probity Medical Research, Waterloo, ON, Canada. · Pubmed 26382906
  • Probity Medical Research, 135 Union Street East, Waterloo, ON, N2J 1C4, Canada. · Comprehensive Center for Inflammation Medicine, University Medical School Schleswig-Holstein, University of Lübeck, Lübeck, Germany. · SCIderm Research Institute and Dermatologikum Hamburg, Hamburg, Germany. · Division of General Dermatology, Department of Dermatology, Medical University of Vienna, Vienna, Austria. · Dalhousie University, Halifax, NS, Canada. · Laboratory for Investigative Dermatology, The Rockefeller University, New York, NY, U.S.A. · Department of Dermatology, Tufts Medical Center, Boston, MA, U.S.A. · Department of Dermatology, The Jikei University School of Medicine, Tokyo, Japan. · Merck & Co., Inc., Kenilworth, NJ, U.S.A. · Pubmed 26042589
  • Probity Medical Research, Waterloo, ON, Canada. · Eastern Virginia Medical School and Virginia Clinical Research, Inc., Norfolk, VA, U.S.A. · MEDTOX Scientific, Inc., St. Paul, MN, U.S.A. · Astellas Pharma Global Development, Northbrook, IL, U.S.A. · The Rockefeller University, New York, NY, U.S.A. · Pubmed 25704750
2014
  • Probity Medical Research, 135 Union Street East, Waterloo, ON, N2J 1C4, Canada. · Pubmed 23465037
2013
2012
2011
9 Other Locations Show
Yearly article counts 01203142210
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.